Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
BlackRock Future Health ETF (BMED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: BMED (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 5% | Avg. Invested days 48 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  2.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Volume (30-day avg) - | Beta 0.82 | 52 Weeks Range 20.57 - 27.02 | Updated Date 06/29/2025 |
52 Weeks Range 20.57 - 27.02 | Updated Date 06/29/2025 |
Upturn AI SWOT
BlackRock Future Health ETF
ETF Overview
Overview
The BlackRock Future Health ETF (BDOC) seeks to provide investment results that correspond to the performance of the iSTOXX FactSet Breakthrough Healthcare Index. It focuses on companies involved in innovative healthcare technologies and services.
Reputation and Reliability
BlackRock is one of the world's largest asset managers with a strong reputation and long track record.
Management Expertise
BlackRock has extensive experience in managing ETFs across various sectors and strategies.
Investment Objective
Goal
To track the investment results of an index composed of developed and emerging market companies that are expected to benefit from advances in healthcare technology and services.
Investment Approach and Strategy
Strategy: The ETF aims to replicate the performance of the iSTOXX FactSet Breakthrough Healthcare Index.
Composition The ETF primarily holds stocks of companies involved in genomics, biotechnology, pharmaceuticals, medical devices, healthcare IT, and telehealth.
Market Position
Market Share: BDOC has a smaller market share compared to broader healthcare ETFs.
Total Net Assets (AUM): 54879119
Competitors
Key Competitors
- XLV
- IBB
- XBI
- ARKG
Competitive Landscape
The ETF industry in the healthcare sector is highly competitive. BDOC focuses on innovative healthcare, while competitors such as XLV are broad market-cap-weighted healthcare ETFs. ARKG focuses on genomic revolution and IBB is on the biotechnology sector. BDOC's advantage lies in its targeted focus on future health, but it faces challenges in attracting assets due to its smaller size and less established track record.
Financial Performance
Historical Performance: Historical performance data unavailable due to the prompt's limitation.
Benchmark Comparison: Benchmark comparison unavailable due to the prompt's limitation.
Expense Ratio: 0.3
Liquidity
Average Trading Volume
BDOC's average trading volume is relatively low compared to more established healthcare ETFs, indicating moderate liquidity.
Bid-Ask Spread
BDOC's bid-ask spread can be wider than larger, more liquid ETFs, increasing the cost of trading.
Market Dynamics
Market Environment Factors
BDOC is influenced by factors such as advancements in healthcare technology, regulatory changes, and demographic trends.
Growth Trajectory
BDOC's growth is tied to the adoption of future health technologies and the performance of the underlying companies within the index; changes to strategy and holdings may occur to maintain index tracking.
Moat and Competitive Advantages
Competitive Edge
BDOC's competitive advantage lies in its focused exposure to companies at the forefront of healthcare innovation, offering investors a targeted approach to capitalize on emerging trends. It selects companies with the highest breakthrough potential. Blackrock's solid reputation and brand recognition should encourage investments. Its focus is more specific than broader healthcare ETFs. The ETF's specialized focus and screening process may result in higher growth.
Risk Analysis
Volatility
BDOC's volatility is expected to be higher than broader healthcare ETFs due to its focus on growth-oriented companies.
Market Risk
BDOC is subject to market risk, including sector-specific risks related to healthcare regulations, technology adoption, and competition.
Investor Profile
Ideal Investor Profile
BDOC is suitable for investors seeking targeted exposure to the future health sector and willing to accept higher volatility for potential growth.
Market Risk
BDOC is best suited for long-term investors with a higher risk tolerance.
Summary
BlackRock Future Health ETF (BDOC) offers targeted exposure to innovative healthcare companies. The ETF's focus on future health technologies makes it more volatile, but it also allows investors to capitalize on growth in niche sectors. Investors must be willing to take on risk for potential gains. BlackRock's reputation and management experience are advantages, but the fund must be compared to other ETFs in the same sector and take into account AUM, trading volume and bid/ask spread.
Peer Comparison
Sources and Disclaimers
Data Sources:
- BlackRock Official Website
- iSTOXX FactSet Breakthrough Healthcare Index Fact Sheet
- Various ETF Data Providers
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Market conditions can change rapidly, and investors should consult with a financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BlackRock Future Health ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.